LifeSignals Receives EU MDR Certification for UbiqVue™ 2A Multiparameter System

LifeSignals Receives EU MDR Certification for UbiqVue™ 2A Multiparameter System

Cloud-Based System, Featuring Wearable Biosensor with Chest-Based SpO2, Enables Active Patient Monitoring Across Hospital and Out-of-hospital Care Settings Replaces time-consuming manual spot checking with continuous, near real-time active patient...

Allianz Partners Group has appointed Michael Buttstedt as Chief Financial Officer and Board Member

Allianz Partners Group has appointed Michael Buttstedt as Chief Financial Officer and Board Member

PARIS, Nov. 28, 2024 /PRNewswire/ -- Allianz Partners, a world leader in insurance and assistance services, has announced that Michael Buttstedt has taken on the role of Chief Financial Officer and Board Member of Allianz Partners Group, since...

Allianz Partners has appointed Michael Buttstedt as Chief Financial Officer and Board Member

Allianz Partners has appointed Michael Buttstedt as Chief Financial Officer and Board Member

PARIS, Nov. 28, 2024 /PRNewswire/ -- Allianz Partners, a world leader in insurance and assistance services, has announced that Michael Buttstedt has taken on the role of Chief Financial Officer and Board Member of Allianz Partners, since September...

LifeSignals Receives FDA 510(k) Approval for UbiqVue™ 2A Multiparameter System

LifeSignals Receives FDA 510(k) Approval for UbiqVue™ 2A Multiparameter System

Cloud-Based System, Featuring Wearable Biosensor with Chest-Based SpO2, Enables Active Patient Monitoring Across Hospital and Out-of-hospital Care Settings Replaces time-consuming manual spot checking with continuous, near real-time active patient...

menu
menu